Showing results (61-70 of 108) with videos related to

Sort By:
Pageof 11
Urology|February 5, 2025
Implementing and Optimizing Universal Germline Genetic Testing for Patients With Prostate Cancer in Clinical PracticeNeal Shore, Andrew J Armstrong, Pedro Barata, et al.
Pharmacy (Basel, Switzerland)|January 23, 2020
Development of a Platform to Align Education and Practice: Bridging Academia and the Profession in PortugalFilipa Alves da Costa, Ana Paula Martins, Francisco Veiga, et al.
Investigational New Drugs|May 1, 2019
Randomized phase II trial of neoadjuvant everolimus in patients with high-risk localized prostate cancerVadim S Koshkin, Maria C Mir, Pedro Barata, et al.
Frontiers in Immunology|March 4, 2022
Cannabidiol and Terpene Formulation Reducing SARS-CoV-2 Infectivity Tackling a Therapeutic StrategySusana Santos, Pedro Barata, Adilia Charmier, et al.
Frontiers in Oncology|November 16, 2020
Outcomes With First-Line PD-1/PD-L1 Inhibitor Monotherapy for Metastatic Renal Cell Carcinoma (mRCC): A Multi-Institutional CohortPedro Barata, Whitley Hatton, Arpita Desai, et al.
Journal for Immunotherapy of Cancer|August 14, 2020
Clinical activity of pembrolizumab in metastatic prostate cancer with microsatellite instability high (MSI-H) detected by circulating tumor DNAPedro Barata, Neeraj Agarwal, Roberto Nussenzveig, et al.
Oncotarget|September 22, 2018
Prevalence of MDM2 amplification and coalterations in 523 advanced cancer patients in the MD Anderson phase 1 clinicVikas Dembla, Neeta Somaiah, Pedro Barata, et al.
Clinical Genitourinary Cancer|May 19, 2021
Clinical Outcomes of Platinum-ineligible Patients with Advanced Urothelial Carcinoma Treated With First-line PD1/L1 InhibitorsGregory R Pond, Archana Agarwal, Moshe Ornstein, et al.
JCO Oncology Practice|April 10, 2025
Gender Disparities in Citations and Altmetric Attention Score in OncologyRebecca A Campbell, Emma Helstrom, Lauren Chew, et al.
JCO Precision Oncology|September 28, 2023
Pan-Cancer Prevalence of Microsatellite Instability-High (MSI-H) Identified by Circulating Tumor DNA and Associated Real-World Clinical OutcomesPashtoon Murtaza Kasi, Leslie A Bucheit, Jiemin Liao, et al.
Pageof 11